Document is current
Any future updates will be listed below
-
Authors
Robert, Stephanie M.
Toth, Allison
Lev, Sapir
Bowden, Stephen G.
Yu, Yao
Imber, Brandon S.
Boire, Adrienne
Drago, Joshua Z.
Modi, Shanu
Moss, Nelson S. https://orcid.org/0000-0002-0930-1681
-
Funding
Funding for this research was provided by:
Cancer Center Grant (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 12 May 2025
First Online: 5 June 2025
Declarations
:
: Financial Interests: SMR, AT, SL, SGB declare that they have no financial interest. Y.Y. has received funding from EMD Serono. B.S.I reports research grants (to institution) from Novartis, Kazia Therapeutics, GT Medical Technologies, AstraZeneca, and Bayer outside the submitted work and serves as a consultant to GT Medical Technologies. A.B. is a Consultant for Arix Biosciences, and has patents related to methods for treating brain metastasis (US Patent 10,413,522) and modulating permeability of the blood–CSF barrier (US Provisional Application Number 62/258,044. J.D. receives funding and honoraria from the following: Intellisphere LLC (Honoraria for talks), AZ (Research Funding AND Consulting), Genagon (Consulting), AmMax Bio (Consulting), NuProbe (Consulting), Revelio Therapeutics (Consulting), MEDACorp (Consulting), Merck (Research Funding), Baird Conferences (Consulting). S.M. received institutional research support from Genentech, Astra Zeneca, Seattle Genetics, Pfizer, Daiichi Sankyo, Duality Bio, D3 Bio, Nuvation Bio, BioNTech; and is a scientific consultant/advisor/speaker for Daiichi Sankyo, Eli Lilly, Genentech, Gilead, Macrogenics, Glaxo-Smith Kline, Seattle Genetics, Pfizer, Gilead, BMS, Nuvation Bio, D3 Bio, AstraZeneca, BioNTech, Boehringer Ingelheim, Avacta. N.S.M receives honoraria from Daiichi Sankyo and Varian, consulting fees from AstraZeneca, and research funding (to institution) from AstraZeneca, Amgen, GT Medical Technologies.
